OWCP Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume750.00
Average Volume (3M)N/A
Market Cap
$497.00
Enterprise Value-$3.46M
Total Cash (Recent Filing)$1.47M
Total Debt (Recent Filing)$47.00K
Price to Earnings (P/E)―
Beta-3.90
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding497,498,350
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-1.24
Price to Book (P/B)-162.34
Price to Sales (P/S)0.00
P/FCF Ratio-606.45
Enterprise Value/Market Cap-6.96K
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
OWCP FAQ
What was OWC Pharmaceutical Research Corp’s price range in the past 12 months?
OWC Pharmaceutical Research Corp lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is OWC Pharmaceutical Research Corp’s market cap?
OWC Pharmaceutical Research Corp’s market cap is $497.00.
When is OWC Pharmaceutical Research Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were OWC Pharmaceutical Research Corp’s earnings last quarter?
OWC Pharmaceutical Research Corp released its earnings results on May 15, 2018. The company reported -$0.007 earnings per share for the quarter.
Is OWC Pharmaceutical Research Corp overvalued?
According to Wall Street analysts OWC Pharmaceutical Research Corp’s price is currently Overvalued.
Does OWC Pharmaceutical Research Corp pay dividends?
OWC Pharmaceutical Research Corp does not currently pay dividends.
What is OWC Pharmaceutical Research Corp’s EPS estimate?
OWC Pharmaceutical Research Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OWC Pharmaceutical Research Corp have?
OWC Pharmaceutical Research Corp has 497,498,350 shares outstanding.
What happened to OWC Pharmaceutical Research Corp’s price movement after its last earnings report?
OWC Pharmaceutical Research Corp reported an EPS of -$0.007 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of OWC Pharmaceutical Research Corp?
Currently, no hedge funds are holding shares in OWCP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OWC Pharmaceutical Research Corp
OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.
InMed Pharmaceuticals
―
Enveric Biosciences
―
IN8bio
―
HCW Biologics
―
Bluejay Diagnostics
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors